What happens when intelligence is no longer something you own—but something you access? In The Borrowed Mind, John Nosta explores the radical shift from human-centered thinking to a new era of shared cognition with AI. This keynote unpacks how decision-making, creativity, and even identity are being reshaped as we “borrow” intelligence from machines. With sharp insight and real-world implications, Nosta challenges leaders to rethink what it means to think, act, and lead in an age where the mind is no longer singular—but networked.
We have the instruments. We hired the musicians. So why does pharma marketing still sound like a garage band? This provocative opener unpacks why having an omnichannel strategy is table stakes — and orchestrating it is the real competitive advantage. Expect brutal honesty, live audience polling, and a new framework for 2026 and beyond.
Every pharma company has run an AI pilot. Most of them are gathering dust. This session isolates the pivotal decisions that separate companies still experimenting from those running AI at enterprise scale — covering model governance, content supply, data readiness, change management, and why your biggest blocker isn't technology.
Pharma marketers are sitting on a goldmine of data, but it often lives in silos. This session explores how uniting digital engagement signals with syndicated datasets can unlock a true 360° view of HCP behavior. Learn how leading teams are overcoming integration challenges, ensuring compliance, and transforming raw data into actionable insights that drive precision targeting and smarter engagement strategies.
Hands-on and fast-paced. Attendees bring their laptops and leave with five GenAI content workflows designed specifically for pharma's regulatory environment. Learn how leading brands are using generative AI to cut content cycle times by 40% without sacrificing compliance — and what prompts, guardrails, and review workflows make it possible.
Three pharma marketing leaders and one agency strategist go deep on what it actually takes to personalize at the physician level. From behavioral analytics to channel preference engines, this session gives attendees a practical blueprint — and a frank look at where most companies are still falling short.
How should pharmaceutical companies adjust their approaches to better support healthcare professionals and enhance the overall HCP experience moving forward?
Where do data analytics and technology intersect within the HCP Experience?
As we move forward, what role do you believe data analytics and AI will play in optimizing the HCP experience for both healthcare professionals and patients, and how can pharmaceutical companies leverage these tools effectively?
Which digital (all) channels should HCP-driven brands be focusing on for their own digital strategies in a post-pandemic world?
How might the Pharma-Provider experience differ in the future compared to the present state?
Every pharma brand has run a GenAI content pilot. Most have discovered the same uncomfortable truth: AI is a magnifier. When your strategy is clear, your brand voice is documented, and your MLR process is defined, AI accelerates everything. When they're not, it scales the chaos. In this candid talk, a senior pharma brand marketer pulls back the curtain on what it actually took to build an AI-powered content engine that survives medical-legal-regulatory review, holds up to brand standards, and produces material HCPs and patients genuinely engage with. No vendor pitch. No theory. Just the real lessons from someone who learned most of them the hard way. You'll leave with a clear answer to the question the industry keeps dancing around: it's not about whether AI can write pharma content — it's about whether your organization is ready to use it well.
Interactive and collaborative. Attendees work in cross-functional teams to map a patient or HCP journey from awareness to adherence — identifying gaps, prioritizing channels, and defining the metrics that matter. Facilitated by an experienced journey design strategist, this workshop produces a take-home framework every marketer can apply Monday morning.
Launch failures are rarely about the science. They're about the strategy, the timing, and the execution. This high-energy panel brings together three commercial launch leaders to share what separates successful launches from expensive disappointments — covering HCP targeting, patient activation, payer access, and the role of AI in launch readiness.
The old model: reach more people, more often. The new model: reach the right people, at the right moment, with the right message, on the right channel. This talk dismantles the volume-first mindset that's been costing pharma brands millions in wasted spend — and introduces the precision engagement framework that's replacing it.
The agency model is under pressure. Clients want more speed, more data fluency, more regulatory knowledge, and more creative courage — often for less. This frank panel, featuring both brand-side and agency-side leaders, explores what great partnership looks like in 2026, and what both sides need to change to get there.
A candid, forward-looking conversation between two industry visionaries about what's coming next — from AI agents that manage entire HCP relationships autonomously, to regulatory frameworks that haven't been written yet. Equal parts inspiring and sobering. Includes live Q&A from the audience.
Healthcare has been episodic for decades. The brands winning in 2026 are designing for continuity. This session shares how one rare disease company transformed its patient engagement model from campaign-based outreach to a longitudinal care relationship — and the commercial results that followed.
The death of the pharma sales rep has been predicted for 20 years. It still hasn't happened. But the role has fundamentally changed. This talk makes the case for the hybrid model: where digital touchpoints and personal relationships work in concert — and explains how the best companies are training, incentivizing, and deploying field teams for the omnichannel era.
Direct-to-consumer advertising told patients a drug existed. Direct-to-patient platforms help them navigate their entire care journey. This session maps the evolution and gives brand strategists a clear-eyed view of what it takes to build a DTP platform that generates real-world data, drives adherence, and creates genuine patient loyalty.
Today's patients arrive at appointments armed with research, opinions, and alternatives. This talk reframes the empowered patient not as a challenge but as your greatest marketing opportunity — and shows how synchronizing brand messaging between patients and providers creates a shared knowledge environment that accelerates trust and treatment decisions.
The best CX is invisible. Patients don't notice the touchpoints — they just feel understood, supported, and seen. This session takes the audience behind the scenes of a best-in-class patient experience program, revealing the architecture, the decisions, and the design principles that transformed a legacy brand's relationship with its community.
Clicks are not conversions. Impressions are not influence. In this intimate fireside chat, a Chief Marketing Officer and a measurement strategist dismantle the industry's addiction to volume metrics and offer a practical framework for measuring intent-driven engagement — the kind that actually moves scripts and shapes patient outcomes.
The old model: reach more people, more often. The new model: reach the right people, at the right moment, with the right message, on the right channel. This talk dismantles the volume-first mindset that's been costing pharma brands millions in wasted spend — and introduces the precision engagement framework that's replacing it.
